Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director · EXECUTIVE CHAIRMAN | November 10, 2021 | December 08, 2021 |
| CATERPILLAR INCCAT · Entity 2808 | Director | March 01, 2022 | March 02, 2022 |
| MCDONALDS CORPMCD · Entity 2849 | Director | December 31, 2025 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date November 10, 2021 · Filed December 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 3,092,852 |
Ending reported balance
After 2021-11-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-11-10 · Gift · Disposed 693 · Balance 3,103,252 Row 2 · 2021-11-12 · Gift · Disposed 10,400 · Balance 3,092,852 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 35,789 |
Reported balance
Holding disclosure · report date 2021-11-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 35,789 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
CATERPILLAR INC
Report date March 01, 2022 · Filed March 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,382 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Tax withholding · Disposed 293 · Balance 8,382 F1: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes adjustments for dividends accrued.
MCDONALDS CORP
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 23,286.12 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 670.75 · Balance 23,286.12 F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4: Includes shares acquired through dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan").
F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation.
F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board.
F4: Includes shares acquired through dividend reinvestment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 530,000 | $0.00 Strike: $26.70 | $0.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · derivative · entry 31 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 530,000 shares Expires 2018-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,377 | $54.46 | $129,439.54 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,401,027 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 13,800 | $54.45 | $751,410.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,403,404 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,501 | $54.45 | $190,611.95 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417,204 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,150 | $54.44 | $498,126.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 27 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,420,705 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,833 | $54.44 | $589,694.36 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 26 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,429,855 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 19,665 | $54.43 | $1,070,365.95 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 25 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,440,688 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 21,402 | $54.43 | $1,164,803.85 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,460,353 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 39,699 | $54.42 | $2,160,419.58 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481,755 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.42 | $5,441.75 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,521,454 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,167 | $54.42 | $444,407.31 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,521,554 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 24,651 | $54.41 | $1,341,260.91 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,529,721 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.41 | $5,440.75 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554,372 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,181 | $54.41 | $771,517.31 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554,472 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 19,900 | $54.40 | $1,082,560.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,568,653 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.40 | $5,439.75 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,588,553 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,435 | $54.40 | $295,636.83 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,588,653 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 27,636 | $54.39 | $1,503,122.04 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594,088 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,502 | $54.39 | $462,381.27 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,621,724 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 16,446 | $54.38 | $894,333.48 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,630,226 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,199 | $54.38 | $282,695.63 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,646,672 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,035 | $54.37 | $436,862.95 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,651,871 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,407 | $54.37 | $130,856.56 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,659,906 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,450 | $54.36 | $404,982.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,662,313 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,650 | $54.36 | $144,040.75 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669,763 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $54.35 | $43,480.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,672,413 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $54.35 | $16,303.50 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,673,213 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $54.34 | $54,340.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,673,513 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $54.33 | $152,124.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,674,513 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $54.33 | $32,595.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,677,313 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 530,000 | $26.70 | $14,149,569.00 |
DisclosureSEC source: 0001179110-17-015154 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,677,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $54.59 | $152,852.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 30 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,279,290 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 505 | $54.59 | $27,565.43 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 29 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282,090 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,101 | $54.58 | $114,672.58 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 28 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282,595 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 692 | $54.58 | $37,765.90 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 27 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,284,696 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,001 | $54.57 | $327,474.57 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 26 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,285,388 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.57 | $10,913.50 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 25 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,291,389 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,902 | $54.57 | $103,782.63 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 24 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,291,589 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,345 | $54.56 | $291,623.20 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,293,491 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,660 | $54.56 | $90,561.30 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,298,836 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,512 | $54.55 | $82,479.60 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,300,496 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $54.55 | $21,818.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302,008 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $54.54 | $65,448.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302,408 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $54.54 | $43,628.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,303,608 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,300 | $54.53 | $398,069.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,304,408 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,799 | $54.53 | $98,090.48 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 16 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,311,708 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,200 | $54.52 | $174,464.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,313,507 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.52 | $5,451.75 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,316,707 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 607 | $54.52 | $33,090.61 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,316,807 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,600 | $54.51 | $359,766.00 |
DisclosureSEC source: 0001179110-17-015156 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,317,414 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.